Market by Type, Form, Livestock, Application, End-user, and Country | Forecast 2021-2028
Triton’s
report infers that the eubiotics market in Latin America is assessed to
register growth at a compound annual growth rate of 6.82% during the
anticipated period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in this market include:
• Brazil
• Mexico
• Rest of Latin America
In
Latin America, meat and milk consumption are higher, having political and
economic value. Moreover, the annual per capita meat consumption is relatively
higher than in Asia and Africa. In this regard, beef is among the majorly
consumed meat products among consumers. Furthermore, several countries have
restricted the use of antibiotics in animal feeds, which influences the
adoption of eubiotics. Therefore, these factors are likely to create several
growth opportunities for the eubiotics market within the next few years.
As
per estimates, Brazil is the largest feed producer in the region. Therefore,
the growing feed industry majorly supports the growth of the studied market.
Furthermore, over the years, the country increased antimicrobial restriction
with normative instructions, along with banning 25 compounds. The banned
antibiotics include colistin, tiamulin, and tylosin. This increase in the
prohibition of antibiotics supports the adoption of eubiotics to maintain
animal health. Hence, as mentioned above, all the factors supplement the development
of the eubiotics market across Brazil.
Similarly,
the rising animal protein industry, coupled with the significant rise in meat
production and consumption, is expected to open new avenues for the Mexican
eubiotics market over the forecast period.
Novus
International Inc offers animal nutrition solutions for livestock, poultry, and
aquaculture sectors. In addition, the company provides organic acids, feed
supplements, trace minerals, and other related products. Its product line
includes Next Enhance that is primarily formulated to promote a healthy gut
environment for animals. Novus has operations across various regions, including
Latin America.
1. LATIN
AMERICA EUBIOTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON EUBIOTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. EUBIOTICS
AS AN ALTERNATIVE TO ANTIBIOTICS
2.2.2. APPLICATIONS
OF EUBIOTICS IN CALVES' GUT HEALTH
2.2.3. DEVELOPING
FOOD ADDITIVE PLATFORM BASED ON GRAINS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. PRODUCT
LAUNCHES
2.6.4. EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISING
MEAT CONSUMPTION
2.7.2. GROWING
AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH
2.7.3. INCREASING
DEMAND MANUFACTURED FEEDS
2.8. MARKET
CHALLENGES
2.8.1. UNAWARENESS
ABOUT EUBIOTICS
2.9. MARKET
OPPORTUNITIES
2.9.1. GOVERNMENT
SUPPORT FOR EUBIOTICS USE
2.9.2. PROBIOTICS
SPRAY COATINGS
2.9.3. ESSENTIAL
OILS FOR NECROTIC ENTERITIS
3. LATIN
AMERICA EUBIOTICS MARKET OUTLOOK - BY TYPE
3.1. PROBIOTICS
3.2. ORGANIC
ACID
3.3. PREBIOTICS
3.4. ESSENTIAL
OILS
4. LATIN
AMERICA EUBIOTICS MARKET OUTLOOK - BY FORM
4.1. DRY
4.2. LIQUID
5. LATIN
AMERICA EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK
5.1. SWINE
5.2. POULTRY
5.3. RUMINANTS
5.4. AQUACULTURE
5.5. OTHER
LIVESTOCK
6. LATIN
AMERICA EUBIOTICS MARKET OUTLOOK - BY APPLICATION
6.1. GUT
HEALTH
6.2. IMMUNITY
6.3. YIELD
MANAGEMENT
6.4. OTHER
APPLICATIONS
7. LATIN
AMERICA EUBIOTICS MARKET OUTLOOK - BY END-USER
7.1. ANIMALS
7.2. HUMANS
8. LATIN
AMERICA EUBIOTICS MARKET – REGIONAL OUTLOOK
8.1. BRAZIL
8.2. MEXICO
8.3. REST
OF LATIN AMERICA
9. COMPETITIVE
LANDSCAPE
9.1. ANPARIO
PLC
9.2. ARCHER
DANIELS MIDLAND
9.3. BASF
SE
9.4. BEHN
MEYER GROUP
9.5. BENEO
GMBH
9.6. CARGILL
INC
9.7. CHR
HANSEN HOLDING A/S
9.8. DUPONT
DE NEMOURS INC
9.9. KEMIN
INDUSTRIES INC
9.10. KONINKLIJKE
DSM NV
9.11. LALLEMAND
INC
9.12. LESAFFRE
9.13. NEOSPARK
DRUGS AND CHEMICALS PRIVATE LIMITED
9.14. NOVUS
INTERNATIONAL INC
9.15. YARA
INTERNATIONAL ASA
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: COUNTRIES WITH
THE HIGHEST ANNUAL MEAT CONSUMPTION
TABLE 4: MAJOR LIVESTOCK
DISEASES IN THE WORLD
TABLE 5: LATIN AMERICA
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: LATIN AMERICA EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 4: LATIN AMERICA EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN
$ MILLION)
FIGURE 5: LATIN AMERICA EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 6: LATIN AMERICA EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028
(IN $ MILLION)
FIGURE 7: LATIN AMERICA EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)
FIGURE 8: LATIN AMERICA EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $
MILLION)
FIGURE 9: LATIN AMERICA EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $
MILLION)
FIGURE 10: LATIN AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028
(IN %)
FIGURE 11: LATIN AMERICA EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $
MILLION)
FIGURE 12: LATIN AMERICA EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $
MILLION)
FIGURE 13: LATIN AMERICA EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $
MILLION)
FIGURE 14: LATIN AMERICA EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN
$ MILLION)
FIGURE 15: LATIN AMERICA EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028
(IN $ MILLION)
FIGURE 16: LATIN AMERICA EUBIOTICS MARKET, BY APPLICATION, 2020 &
2028 (IN %)
FIGURE 17: LATIN AMERICA EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $
MILLION)
FIGURE 18: LATIN AMERICA EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $
MILLION)
FIGURE 19: LATIN AMERICA EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028
(IN $ MILLION)
FIGURE 20: LATIN AMERICA EUBIOTICS MARKET, BY OTHER APPLICATIONS,
2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA EUBIOTICS MARKET, BY END-USER, 2020 & 2028
(IN %)
FIGURE 22: LATIN AMERICA EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $
MILLION)
FIGURE 23: LATIN AMERICA EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $
MILLION)
FIGURE 24: LATIN AMERICA EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 &
2028 (IN %)
FIGURE 25: BRAZIL EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: MEXICO EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: REST OF LATIN AMERICA EUBIOTICS MARKET 2021-2028 (IN $
MILLION)